Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload (EXCALIBUR)
Status
Conditions
Treatments
Details and patient eligibility
About
This is a prospective, multicenter, non-interventional study. Findings are analyzed using epidemiological methods.
Full description
This NIS shall document the therapy of chronic iron overload in a broad patient population with either of the approved iron chelators in Germany. The choice of patients and the therapy according to the SmPC follows the clinical routine exclusively. The regular observation time per patient is 24 months.
Corresponding to the clinical routine, follow up visits can be documented after approximately 1, 3, 6, 9, 12 and 18 month with a close out visit after 24 month. In case the iron chelator is switched, the visit scheme should be passed through once again.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male and female adult patients suffering from chronic iron overload
- who never received an iron chelator directly before starting an iron chelation therapy
- who received an iron chelation therapy for less than 6 month
- who interrupted an iron chelation therapy for longer than 6 months and will receive an iron chelation therapy again
- who signed the informed consent
Exclusion criteria
Trial design
489 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal